ACNO Dr. Nancy Albert offers her perspectives on heart failure awareness and the work of the Heart Failure Society of America.
Innovative Information Card Helps Heart Failure Patients After Discharge
Heart failure expert and executive nurse leader Dr. Nancy Albert discusses the information card innovation that helps heart failure patients transition from hospital to home, reduces readmissions and more.
ALIVE Trial Offers Hybrid Approach for Ischemic Cardiomyopathy With Residual Scar
An investigational procedure with percutaneous and minimally invasive surgical components promises a new treatment option for a heart failure population with limited alternatives.
Cleveland Clinic Expert Draws Conclusion at Virtual Conference: Heart Transplant/Donor Program Success
Cleveland Clinic Heart, Vascular & Thoracic Institute reaches healthcare leaders in China meeting the needs of healthcare leaders with virtualized solutions.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
By-the-Numbers Snapshots of Our Heart Failure and Electrophysiology Care (Infographic)
Looking for a benchmark for your heart failure or electrophysiology program? Check out some of our key volume and outcome statistics from these subspecialties in this dynamic infographic.
Timely Referral for Transplant or LVAD Is Critical to Heart Failure Outcomes
A new JACC statement makes the case for earlier referral of patients with advanced heart failure. Our experts review the recommendations and the rationale behind them.
‘Bailout’ Ablation for Cardiogenic Shock and Refractory VT for Patients on Mechanical Support
A large case series shows that catheter ablation of refractory ventricular arrhythmia in patients with cardiogenic shock can allow for liberation from mechanical support in most cases.
Exploring the Connection Between Sleep Apnea and Cardiovascular Disease
Sleep apnea is associated with heart failure, atrial fibrillation, stroke, coronary artery disease and cardiovascular mortality. CPAP treatment may reduce the risk of cardiac events, indicate some data.
No. 10 Medical Innovation for 2020: Drugs for Heart Failure with Preserved Ejection Fraction
SGLT2 inhibitors for heart failure with preserved ejection fraction will be the No. 10 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Preliminary Evidence Supports Initiation of Sacubitril-Valsartan in Low-Output Heart Failure
Promising observational data suggest it’s time for a prospective study of this therapy in heart failure patients with reduced ejection fraction and low cardiac output who are receiving IV therapies.